| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 生物活性 | Tifcemalimab (JS004) is a humanized anti-BTLA(B and T lymphocyte attenuation factor)monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding toBTLA, and thus blocks the inhibitory signaling pathway mediated byBTLA. Tifcemalimab can be used in research ofcancer[1]. |
| IC50& Target | Target: BTLA[1] |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com